95 related articles for article (PubMed ID: 27033294)
1. Cerebellar atrophy and muscle weakness: late-onset Tay-Sachs disease outside Jewish populations.
Steiner KM; Brenck J; Goericke S; Timmann D
BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 27033294
[No Abstract] [Full Text] [Related]
2. Atypical presentation of late-onset Tay-Sachs disease.
Deik A; Saunders-Pullman R
Muscle Nerve; 2014 May; 49(5):768-71. PubMed ID: 24327357
[TBL] [Abstract][Full Text] [Related]
3. Late onset Tay-Sachs disease in mice with targeted disruption of the Hexa gene: behavioral changes and pathology of the central nervous system.
Miklyaeva EI; Dong W; Bureau A; Fattahie R; Xu Y; Su M; Fick GH; Huang JQ; Igdoura S; Hanai N; Gravel RA
Brain Res; 2004 Mar; 1001(1-2):37-50. PubMed ID: 14972652
[TBL] [Abstract][Full Text] [Related]
4. Paranoid delusion as lead symptom in two siblings with late-onset Tay-Sachs disease and a novel mutation in the HEXA gene.
Stendel C; Gallenmüller C; Peters K; Bürger F; Gramer G; Biskup S; Klopstock T
J Neurol; 2015; 262(4):1072-3. PubMed ID: 25860343
[No Abstract] [Full Text] [Related]
5. Tay-Sachs disease in an Arab family due to c.78G>A HEXA nonsense mutation encoding a p.W26X early truncation enzyme peptide.
Haghighi A; Masri A; Kornreich R; Desnick RJ
Mol Genet Metab; 2011 Dec; 104(4):700-2. PubMed ID: 21967858
[TBL] [Abstract][Full Text] [Related]
6. Novel human pathological mutations. Gene symbol: HEXA. Disease: Tay-Sachs disease.
Chin E; Bean L; Coffee B; Hegde MR
Hum Genet; 2009 Aug; 126(2):329. PubMed ID: 19644708
[No Abstract] [Full Text] [Related]
7. Tay-Sachs Disease Presenting as Refractory Epilepsy with Autistic Regression Secondary to a Novel Mutation in HEXA Gene.
Gowda VK; Srinivasan VM; Bhat M; Benakappa A
Indian J Pediatr; 2018 Dec; 85(12):1134-1135. PubMed ID: 30006889
[No Abstract] [Full Text] [Related]
8. Adeno-Associated Virus Gene Therapy in a Sheep Model of Tay-Sachs Disease.
Gray-Edwards HL; Randle AN; Maitland SA; Benatti HR; Hubbard SM; Canning PF; Vogel MB; Brunson BL; Hwang M; Ellis LE; Bradbury AM; Gentry AS; Taylor AR; Wooldridge AA; Wilhite DR; Winter RL; Whitlock BK; Johnson JA; Holland M; Salibi N; Beyers RJ; Sartin JL; Denney TS; Cox NR; Sena-Esteves M; Martin DR
Hum Gene Ther; 2018 Mar; 29(3):312-326. PubMed ID: 28922945
[TBL] [Abstract][Full Text] [Related]
9. Late-onset Tay-Sachs disease: phenotypic characterization and genotypic correlations in 21 affected patients.
Neudorfer O; Pastores GM; Zeng BJ; Gianutsos J; Zaroff CM; Kolodny EH
Genet Med; 2005 Feb; 7(2):119-23. PubMed ID: 15714079
[TBL] [Abstract][Full Text] [Related]
10. Improving accuracy of Tay Sachs carrier screening of the non-Jewish population: analysis of 34 carriers and six late-onset patients with HEXA enzyme and DNA sequence analysis.
Park NJ; Morgan C; Sharma R; Li Y; Lobo RM; Redman JB; Salazar D; Sun W; Neidich JA; Strom CM
Pediatr Res; 2010 Feb; 67(2):217-20. PubMed ID: 19858779
[TBL] [Abstract][Full Text] [Related]
11. Unusual case of Juvenile Tay-Sachs disease.
Cheema HA; Waheed N; Saeed A
BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31519716
[TBL] [Abstract][Full Text] [Related]
12. Identification of two HEXA mutations causing infantile-onset Tay-Sachs disease in the Persian population.
Haghighi A; Rezazadeh J; Shadmehri AA; Haghighi A; Kornreich R; Desnick RJ
J Hum Genet; 2011 Sep; 56(9):682-4. PubMed ID: 21796138
[TBL] [Abstract][Full Text] [Related]
13. Amyotrophy, cerebellar impairment and psychiatric disease are the main symptoms in a cohort of 14 Czech patients with the late-onset form of Tay-Sachs disease.
Jahnová H; Poupětová H; Jirečková J; Vlášková H; Košťálová E; Mazanec R; Zumrová A; Mečíř P; Mušová Z; Magner M
J Neurol; 2019 Aug; 266(8):1953-1959. PubMed ID: 31076878
[TBL] [Abstract][Full Text] [Related]
14. Rapid detection of fetal Mendelian disorders: Tay-Sachs disease.
Guetta E; Peleg L
Methods Mol Biol; 2008; 444():147-59. PubMed ID: 18425478
[TBL] [Abstract][Full Text] [Related]
15. [Tay-Sachs disease].
Tanaka A
Nihon Rinsho; 1993 Sep; 51(9):2281-5. PubMed ID: 8411703
[TBL] [Abstract][Full Text] [Related]
16. Pontocerebellar atrophy is the hallmark neuroradiological finding in late-onset Tay-Sachs disease.
Májovská J; Hennig A; Nestrasil I; Schneider SA; Jahnová H; Vaněčková M; Magner M; Dušek P
Neurol Sci; 2022 May; 43(5):3273-3281. PubMed ID: 34800199
[TBL] [Abstract][Full Text] [Related]
17. Late onset hexosaminidase A deficiency in a young adult.
Peters AS; Markovic K; Schramm A; Schwab S; Heuss D
Eur J Neurol; 2008 Jul; 15(7):e70-1; author reply e72-3. PubMed ID: 18494795
[No Abstract] [Full Text] [Related]
18. Diagnosis and molecular characterization of non-classic forms of Tay-Sachs disease in Brazil.
Rozenberg R; Kok F; Burin MG; Sá Miranda MC; Vasques C; Henriques-Souza AM; Giugliani R; Vainzof M; Pereira LV
J Child Neurol; 2006 Jun; 21(6):540-4. PubMed ID: 16948947
[TBL] [Abstract][Full Text] [Related]
19. Late-onset Tay-Sachs disease presenting with a neuromuscular phenotype-a case series.
Fullam S; Togher Z; Power A; Kennelly L; McHugh JC; O'Dowd S; Tubridy N; Hardiman O; Costigan D; Ryan A; Lefter S; Connolly S; Murphy SM
Eur J Neurol; 2024 Jan; 31(1):e16069. PubMed ID: 37754769
[TBL] [Abstract][Full Text] [Related]
20. Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene.
Myerowitz R
Hum Mutat; 1997; 9(3):195-208. PubMed ID: 9090523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
